Does “MS fatigue” capture the symptom experience?
18 October 2021
The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.
The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.
MS Australia’s advocacy efforts have contributed to a number of subsidised MS medications and disease-modifying therapies (DMTs). New research now shows the effect this has on the outcomes for people living with MS in New Zealand.
As part of our advocacy work at MS Australia, we make many submissions each year, to various Australian Government inquiries and consultations.
MS Australia President, Associate Professor Desmond Graham has received University of Tasmania’s 2021 Award for Outstanding Contribution.
Over $6.7 million dollars will be invested into MS research by the National Health and Medical Research Council (NHMRC) in their funding scheme.
The Federal Health Minister has announced the listing of Kesimpta® (ofatumumab) on the PBS for the treatment of relapsing remitting MS.
His Excellency General the Honourable David Hurley AC DSC (Retd), the Governor-General of Australia, generously gifted a special medallion to MS Australia to award someone who has contributed to our work in significant way.
Australia’s largest ever Paralympic Games team included three athletes living with multiple sclerosis; Emily Petricola, Carol Cooke and Janine Watson.
The Accessible Product Design Alliance is highlighting the struggle with inaccessible products and packaging, experienced by people living with disability.